Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Natus Medical has filed a preliminary prospectus supplement to its effective shelf registration statement relating to a proposed underwritten offering of 3.5 million shares of its common stock.
Subscribe to our email newsletter
The company expects to grant a 30-day option to the underwriters to purchase up to an additional 15% of the shares offered solely to cover over-allotments. All of the shares are being sold by Natus Medical.
All of the shares are being offered by Cowen and Company, and UBS Investment Bank as joint bookrunning managers. Natixis Bleichroeder, Needham & Company, Raymond James & Associates, and Roth Capital Partners, are acting as co-managers.